Evidence map›Paper›PMID 37394509›Full record

Trial reportPediatrics2023

A COVID-19 Testing Preference Study in Schools.

Jennifer E Schuster, Jessie Potts, Rangaraj Selvarangan, Dana Keener Mast, Jennifer L Goldman, School TLC Study Group

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Capture of Group ABioengineering & translational medicine · 2025
    Article
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jennifer E SchusterChildren's Mercy Kansas City, Kansas City, Missouri.
Jessie PottsICF, Atlanta, Georgia.
Rangaraj SelvaranganChildren's Mercy Kansas City, Kansas City, Missouri.
Dana Keener MastICF, Atlanta, Georgia.
Jennifer L GoldmanChildren's Mercy Kansas City, Kansas City, Missouri.
School TLC Study Group
Children's Mercy Hospital · USICF International (United States) · US

Funding

Support for Safe Return to in-Person School: COVID-19 Testing, Learning, and Consultation (School TLC)OT2HD107555 · NICHD · ICF MACRO, INC. · PI GOLDMAN, JENNIFER LYNN, KEENER MAST, DANA · 2021 to 2022
$5.0M
NICHD NIH HHS OT2 HD107555
6 · The paper itself

Abstract

objectivesThe Centers for Disease Control and Prevention identifies in-school COVID-19 testing as a key mitigation strategy to protect students and staff during the COVID-19 pandemic. Both nasal and saliva samples are acceptable, but existing school guidance does not state a preferred test method.

methodsFrom May 2021 through July 2021, we performed a randomized, crossover study in kindergarten through 12th grade (K-12) schools to evaluate student and staff preference for self-collected nasal or saliva testing. Participants performed both collection types and participated in a standardized questionnaire assessing the preferred method.

resultsA total of 135 students and staff participated. Staff, middle school, and high school students preferred the nasal swab (80/96, 83%), whereas elementary students were mixed (20/39, 51% preferred saliva). Reasons reported for preferring the nasal swab included being faster and easier. Reasons reported for preferring saliva included being easier and more fun. Despite their preference, 126 (93%) and 109 (81%) participants would take the nasal swab or saliva test again, respectively.

conclusionsThe anterior nasal test was the preferred testing method by students and staff, although preference varied by age group. Willingness to perform both tests again in the future was high. Identifying the preferred testing modality is important to increase acceptance and participation in COVID-19 in-school testing programs.

Indexed as

COVID-19COVID-19 TestingChildCross-Over StudiesHumansPandemicsSchoolsUnited States

Identifiers

PMID37394509
PMCPMC10312271
OpenAlexW4382918817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.